SEC Filing Summary: General Sales and Leasing, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed on February 25, 2013, by General Sales and Leasing, Inc., a Nevada corporation. The filing reports corporate governance changes and other events effective as of late February 2013. Note: The request metadata references "Xenetic Biosciences, Inc.," but the filing text explicitly identifies the registrant as "General Sales and Leasing, Inc." following a name change.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural changes rather than financial performance.
Material Changes
- Corporate Name Change: Effective February 25, 2013, the company changed its name to "General Sales and Leasing, Inc." following approval by the board of directors and a majority of shareholders.
- Stock Split: The board approved a 10-for-1 forward stock split effective February 28, 2013. The record date was February 25, 2013.
- Security Identifiers: A new CUSIP number (370729105) was assigned to the common stock. The trading symbol remains unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the announcement of the name change and stock split.
Investor Verification Checklist
- Verify the new CUSIP number (370729105) for trading and settlement purposes.
- Confirm the 10-for-1 stock split adjustment in brokerage accounts effective February 28, 2013.
- Ensure the trading symbol has not changed despite the corporate name change.
- Review the attached Certificate of Amendment (Exhibit 3.1) for legal details on the name change.